CrushSCI.com
Journal Selection & Manuscript Polishing Services
Cell Stem Cell journal cover Medicine
Back to journal directory

Review Cycle Records

Cell Stem Cell

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
263Average days
243.5Median days
94Fastest days
460Longest days
1712025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

351 days

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target

AuthorsBérénice Dugué; Pia Wanner; Mayra L. Ruiz Tejada Segura; Mohamed Saad; Lucas Greven; Katrin Götz; Carmen Schalla; Stijn Fuchs; Gerjanne Vroeg in de wei; Hélène F.E. Gleitz; Anna Katharina Galyga; Jessica Ellen Pritchard; Tobias Schlangen; Niklas Lutterbach; Salim Atakhanov; Lina Schmidt; Marie Parrens; Armelle Peyrat; Damien Luque Paz; Marie-Christine Copin; Alexandre Guy; Victor-Emmanuel Brett; Olivier Mansier; Susanne Schmitz; Paul Wanek; Bella Banjanin; Stephani Schmitz; Martina Crysandt; Marian C. Clahsen-van Groningen; Konnie M. Hebeda; Sascha Dietrich; Harald Voehringer; Matthias Meyer-Bender; Kristin Séré; Chloé James; Adam Benabid; Ivan Costa; Charles Dussiau; Rebekka K. Schneider

AffiliationsUniversity of Bordeaux, UMR1034, Inserm, Biology of Cardiovascular Diseases, 33600 Pessac, France; RWTH Aachen University, Department of Cell and Tumor Biology, Faculty of Medicine, 52074 Aachen, Germany; RWTH Aachen University, Institute for Computational Genomics, Faculty of Medicine, Aachen 52074, Germany; Erasmus Medical Center, Department of Developmental Biology, Rotterdam 3015GD, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands; CHU Bordeaux, Department of Pathology, 33000 Bordeaux, France; Angers University, Nantes University, CHU Angers, Inserm, CNRS, CRCI2NA, 49000 Angers, France; CHU Angers, Department of Pathology, 49000 Angers, France; CHU Bordeaux, Laboratory of Hematology, 33000 Bordeaux, France; RWTH Aachen University, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, 52074 Aachen, Germany; University Hospital RWTH Aachen, Department of Nephrology, 52074 Aachen, Germany; Department of Pathology and Clinical Bioinformatics, Erasmus MC Transplant Institute, Rotterdam 3015GD, the Netherlands; Laboratory for Pathology (PAL), 3318 AL Dordrecht, the Netherlands; Radboud University Medical Center, Department of Pathology, 6525 GA Nijmegen, the Netherlands; University Hospital Düsseldorf, Heinrich Heine University, Department of Hematology, Oncology and Clinical Immunology, 40225 Düsseldorf, Germany; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), 69117 Heidelberg, Germany; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany; European Molecular Biology Laboratory, Molecular Systems Biology Unit, 69117 Heidelberg, Germany; German Cancer Research Center (DKFZ), Division of Experimental Hematology, 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany

Source PDF DOI Publisher page
366 days

Splenic extramedullary hematopoiesis in myelofibrosis is shaped by transcriptomic and epigenetic dysregulation

AuthorsRebecca Austin; Madeline H. Kowalski; Xiaoli Wang; Ziyan Lin; Bettina Nadorp; Nicholas Ward; Pier Edoardo Rovatti; Audrey Lasry; Zhengxi Sun; Julia Rojo-Tomillo; Giovanni Gambi; Tejas Patel; Hua Zhou; M.D. Babu Mia; Eduardo Esteva; Igor Dolgalev; Valeria Mezzano; Suhita Ray; Sergei Doulatov; Tatyana Gindin; Sanam Loghavi; Bethan Psaila; Aristotelis Tsirigos; Rahul Satija; Iannis Aifantis; Ronald Hoffman

AffiliationsDepartment of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY 10016, USA; Institute for Systems Genetics, New York University Grossman School of Medicine, New York, NY 10016, USA; New York Genome Center, New York, NY 10013, USA; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Applied Bioinformatics Laboratories, New York University Grossman School of Medicine, New York, NY, USA; Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA; Center for Genomics and Systems Biology, New York University, New York, NY 10003, USA; Translational Immunology Center, New York University, New York, NY 10010, USA; Department of Physiology and Cellular Biophysics, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX3 7DQ, UK

Source PDF DOI Publisher page
94 days

Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrains

AuthorsLouise A. Mesentier-Louro; Camille Goldman; Sebastian Gaese; Alice Buonfiglioli; Dimitrios Kyriakis; Ashley Harlock; Alain Ndayisaba; Emily R. Sartori; Abigail Uchitelev; John F. Fullard; Evelyn Hennigan; Donghoon Lee; Braxton R. Schuldt; Rikki B. Rooklin; Jonathan Barra; Jose Javier Bravo-Cordero; Panos Roussos; Vikram Khurana; Joel W. Blanchard

AffiliationsIcahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Stem Cell Biology and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Macaulay Honors College at Hunter College, New York, NY, USA; Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Mental Illness Research Education, and Clinical Center (VISN 2 South), James J. Peters VA Medical Center, Bronx, NY, USA; Center for Precision Medicine and Translational Therapeutics, James J. Peters VA Medical Center, Bronx, NY, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA

Source PDF DOI Publisher page
109 days

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types

AuthorsXiujie Yang; Qi Yin; Kui Li; Jianze Wang; Rui Song; Haoyi Zhou; Shu Han; Linyu Zhang; Yuwen Zeng; Da Xu; Feng Wang; Shixin Zhou; Yang Yang; Hua Zhu; Chunhong Zheng; Yang Li; Zhi Yang; Xing Yang; Zhaofei Liu

AffiliationsDepartment of Radiation Medicine, School of Basic Medical Sciences, Peking University, Department of Nuclear Medicine, Peking University Third Hospital, Beijing 100191, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, China; Department of Cell Biology, School of Basic Medical Sciences, Peking University Stem Cell Research Center, Peking University, Beijing 100191, China; Breast Center, Peking University Cancer Hospital and Institute, Beijing 100142, China; Frontiers Science Center for Cancer Integrative Omics, Peking University International Cancer Institute, Peking University, Beijing 100191, China; Department of Nuclear Medicine, Peking University People’s Hospital, Beijing 100044, China; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China

Source PDF DOI Publisher page
381 days

Morphogen-guided neocortical organoids with anteroposterior areal identity

AuthorsYuan-Chen Tsai; Hajime Ozaki; Axel A. Almet; Isabel Fleming; Caihao Nie; Songhao Luo; Xinyi Wang; Kaori Shiraiwa; Matthew Jung Min Noh; Sunnyana Trejo; Bret Kiyoshi Sugita; Jiya Dalal; Ruben Alberto Gonzalez; Briana De Jesus; Nate Branco; Gregory Li-Min Chen; Michael J. Gandal; Qing Nie; Momoko Watanabe

AffiliationsDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA; Department of Mathematics, School of Physical Sciences, University of California, Irvine, Irvine, CA 92697, USA; NSF-Simons Center for Multiscale Cell Fate Research, University of California, Irvine, Irvine, CA 92697, USA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Systems Biology, School of Biological Sciences, University of California, Irvine, Irvine, CA 92697, USA; Sue & Bill Gross Stem Cell Research Center, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA

Source PDF DOI Publisher page
258 days

Human iPSC-derived heart valve-like assembloids model valve development and disease pathology

AuthorsYuanhang He; Abbas Jalili; Carter B. Jones; Haoting He; Lameck Beni; Daniel Lamont; Junqi Hu; Macy Yost; Lance A. Davidson; Si-Yang Zheng; Guang Li

AffiliationsDepartment of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15201, USA; Tsinghua Medicine, Tsinghua University, Beijing 100084, China; Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15201, USA; Department of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Department of Electrical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pittsburgh, PA 15260, USA

Source PDF DOI Publisher page
460 days

Human heart valve-like tissues from pluripotent stem cells with enhanced maturation recapitulate inflammatory valve disease

AuthorsHolly K. Voges; Jessica Durrant-Whyte; Michael See; Valerii Iaprintsev; Serene Yeow; Benjamin L. Parker; Kaitlyn Bibby; Ellen Keen; Ingrid King; Adam T. Piers; Anita C. Thomas; Daniel G. Donner; Akriti Varshney; Sara Alaei; David Yoannidis; Timothy Semple; Natalie Charitakis; Jerico Revote; Adriano Morandini; Purva Kumbhar; Rebecca Sutton; Francesca Butera; Edouard G. Stanley; Janice D. Reid; James E. Hudson; Amr H. Allam; Sara Ellis; Lina H.H. Le; James P. Burgess; Sean J. Humphrey; Salvatore Pepe; Hazem Alkazemi; Daniel E. Heath; Mirana Ramialison; Fernando J. Rossello; Christian P. Brizard; David A. Elliott; Alejandro Hidalgo; Enzo R. Porrello

AffiliationsMurdoch Children’s Research Institute, The Royal Children’s Hospital, Melbourne, VIC 3052, Australia; Department of Paediatrics, School of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, VIC 3052, Australia; Novo Nordisk Foundation Center for Stem Cell Medicine, Murdoch Children’s Research Institute, Melbourne, VIC 3052, Australia; Department of Anatomy and Physiology, The University of Melbourne, Parkville, VIC 3052, Australia; Translational Cardiology Center, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Australian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800, Australia; QIMR Berghofer, Brisbane, QLD, Australia; Olivia Newton John Cancer Research Center, Melbourne, VIC 3084, Australia; Department of Biomedical Engineering, The University of Melbourne, Melbourne, VIC 3052, Australia; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC 3052, Australia; Royal Children’s Hospital, Melbourne, VIC 3052, Australia

Source PDF DOI Publisher page
181 days

TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation

AuthorsZhiquan Liu; Siyu Chen; Wenmin Wang; Fan Zhang; Qing Wang; Grzegorz Walkiewicz; Faruk Hossen; Jinqiong Zhou; Yiting Wang; Yang Sun

AffiliationsDepartment of Ophthalmology, Stanford University School of Medicine, 1651 Page Mill Road, Palo Alto, CA 94304, USA; Palo Alto Veterans Administration, Palo Alto, CA, USA

Source PDF DOI Publisher page
201 days

Cardiopedia-Ligand: A ligand-receptor perturbation atlas of human cardiac organoid function and transcriptional state

AuthorsJanice D. Reid; Simon R. Foster; Mary Lor; Alexander S. Hauser; Brendan Griffen; Rebecca L. Fitzsimmons; James E. Hudson

AffiliationsQIMR Berghofer, Brisbane, QLD, Australia; School of Biomedical Sciences, The University of Queensland, St Lucia, Brisbane, QLD, Australia; Department of Pharmacology, Monash University, Melbourne, VIC, Australia; Department of Drug Design and Pharmacology, Center for Pharmaceutical Data Science Education, University of Copenhagen, Copenhagen, Denmark; Dynomics Pty Ltd, Brisbane, QLD, Australia

Source PDF DOI Publisher page
229 days

Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis

AuthorsKarl-Henrik Grinnemo; Ken Braesch-Andersen; Johan O. Wedin; Anna Velica; Ulrika Thelander; Pierre Sabatier; Christian M. Beusch; Oscar E. Simonson; Alice Törne; Ulrika Felldin; Olga Gritsenko; Kyong-Su Park; Rossella Crescitelli; Nils Ågren; Stephan Meinke; Ayman Abouzayed; Olivia Wegrzyniak; Andriana Putri; Patricia Hedenqvist; Anneli Rydén; Alexandra Leijon; Lisa Lindström; Irina Velikyan; Evren Alici; Johannes Wikström; Li Ming Gan; Tomas Lorant; Makiko Kumagai-Braesch; Elisabeth Ståhle; Olle Korsgren; Karin Fromell; Kristina Nilsson-Ekdahl; Bo Nilsson; Jan Lötvall; Marianne Jensen-Waern; Jesper V. Olsen; Daniel W. Hagey; Samir E.L. Andaloussi; Katarina Le Blanc; Stefan James; Olof Eriksson; Sergey Rodin

AffiliationsCardio-Thoracic Translational Medicine (CTTM) Lab, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Cardiothoracic Surgery and Anesthesiology, Uppsala University Hospital, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Pathology, Uppsala University Hospital, Uppsala, Sweden; Novo Nordisk Foundation Center for Protein Research, Department of Cellular and, Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; Pathology Advanced Translational Research Unit (PATRU), Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA; Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Sweden; Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, 141 52, Stockholm, Sweden; Science For Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; Antaros TracerAB, Uppsala, Sweden; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden; Department of Animal Biosciences, Swedish University of Agricultural Sciences, Uppsala, Sweden; PET center, Uppsala University Hospital, Uppsala, Sweden; Ribocure Pharmaceuticals AB, Sweden; SuZhou Ribo Life Science Co. Ltd., China; Department of Cardiology, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Surgical Sciences, Section of Transplant Surgery, Uppsala University, Uppsala, Sweden; Centre of Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden; Department of Laboratory Medicine, Unit for Biomolecular and Cellular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Huddinge, Sweden; Karolinska ATMP Center, ANA Futura, Huddinge, Sweden; Department of Laboratory Medicine, Division of Microbiology, Karolinska Institutet, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Clinical Physiology and Cardiology, Uppsala University Hospital, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala, Sweden

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.